Real‐World Assessment of Clinical Outcomes Among First‐Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group

BACKGROUND: International Metastatic Renal Cell Carcinoma (mRCC) Database Consortium (IMDC) risk groups are important when considering therapeutic options for first‐line treatment. MATERIALS AND METHODS: Adult patients with clear cell mRCC initiating first‐line sunitinib between 2010 and 2018 were i...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncologist
Auteurs principaux: Savard, Marie‐France, Wells, J. Connor, Graham, Jeffrey, Dudani, Shaan, Steinharter, John A., McGregor, Bradley A., Donskov, Frede, Bjarnason, Georg A., Vaishampayan, Ulka N., Hansen, Aaron R., Iafolla, Marco A.J., Zanotti, Giovanni, Huynh, Lynn, Chang, Rose, Duh, Mei S., Heng, Daniel Y.C.
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons, Inc. 2020
Sujets:
Genitourinary Cancer
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7216460/
https://ncbi.nlm.nih.gov/pubmed/31971318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0605
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires